CME Group has announced a leadership transition that will see long-time CEO Terry Duffy step down in March 2027, ending a spell spanning more than two decades at the top of the derivatives exchange operator.
Duffy will move to the role of executive chairman, while current president and CFO Lynn Fitzpatrick will assume the CEO role and join the board, the company said.
Leadership transition plan
Duffy has led CME Group since 2002, when he became Chairman, and subsequently took over as CEO in 2016. During his time in charge, the company expanded its global presence and reshaped its operations.
He oversaw the Chicago Mercantile Exchange’s transition from floor trading to electronic markets and led major acquisitions. These include the merger with the Chicago Board of Trade in 2007 and the purchase of the New York Mercantile Exchange in 2008. Both deals strengthened the Chicago Mercantile Exchange’s position in global derivatives trading.
The company has also grown widely. The Chicago Mercantile Exchange reported an average daily volume of 28.1 million contracts last year and now has a market capitalization of more than $95 billion.
Duffy said he plans to remain active in the business during the transition. “I’m glad our company is doing well and I couldn’t be more optimistic about its future potential,” he said.
Fitzpatrick to take over
Fitzpatrick will assume the CEO role after holding several senior positions at the Chicago Mercantile Exchange. She became CFO in 2023 and was promoted to president and CFO in 2024. She joined the company in 2006 and previously worked in investment banking at Credit Suisse and UBS. CME said Duffy will continue to work closely with Fitzpatrick as CEO.
The last notable leadership shift at CME was a reshuffle in late 2024 in which Lynn Fitzpatrick was promoted to President and CFO and Susan Sprague was promoted to Chief Operating Officer while longtime COO Julie Holzrichter moved into an advisory role.
This package of changes, along with the extension of Terry Duffy’s employment agreement until the end of 2026, has been formulated by the CME as a leadership update to support the future growth of the derivatives franchise.
This article was written by Jared Kirroy at www.financemagnates.com.
Source link
